Search

Scientists came to give talks and celebrate the achievements that the program has made under the leadership of Kathryn Anderson.

… Wednesday, November 21, 2018 A female scientist speaking Ruth Lehmann, Director of the Skirball Institute of Biomolecular Medicine at NYU Langone Health A male scientist speaking Siegfried Roth, a professor at the Institute for Zoology Biocenter at the University of Cologne, in Germany A female scientist

New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC).

… Thursday, June 3, 2021 New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC). The phase

Learn about the breast cancer type called ductal carcinoma in situ (DCIS) and how doctors decide on the best treatment for each person.

… Tuesday, October 12, 2021 Summary Ductal carcinoma in situ (DCIS) makes up approximately 20% of newly diagnosed breast cancers. But patients are often confused about DCIS, what it means, and what to do about it. We asked MSK surgeon Andrea Barrio to provide some insight into the disease and its treatments

While there has been remarkable progress in the number of people surviving with stage 4 cancer, MSK remains dedicated to research that will spur much needed advances.

… Friday, January 16, 2026 There’s good news about surviving stage 4 cancer — meaning cancer that has spread to other parts of the body — according to the new  Cancer Facts and Figures report from the American Cancer Society. In a sign of remarkable progress over the past two decades, more than one-third

Androgen deprivation therapy may depress testosterone for prolonged periods in older patients, or those who are on the treatment for more than six months, increasing the risk of associated adverse events, according to the results of our recent retrospective study.

… Tuesday, October 8, 2019 Despite the intention to reduce testosterone temporarily, androgen deprivation therapy (ADT) may lower it for prolonged periods in patients over the age of 65 or those who take ADT for more than six months, according to the results of our recent retrospective study. Given the

An MSK clinical trial is helping Gail Goode overcome multiple myeloma and sheds new light on how cancer affects people of diverse ethnic backgrounds.

… Tuesday, September 3, 2024 There is an urgent need to recruit more diverse patients into cancer clinical trials . One reason it’s so important is that researchers are learning that certain types of cancer occur more frequently in people with certain ancestries. For example:   African — people of African

Un ensayo clínico de MSK está ayudando a Gail Goode a superar el mieloma múltiple y arroja nueva luz sobre cómo el cáncer afecta a personas de diversos orígenes étnicos.

… Tuesday, September 3, 2024 Existe una necesidad urgente de reclutar a pacientes más diversos en los ensayos clínicos de cáncer . Una de las razones por las que es tan importante es que los investigadores están descubriendo que ciertos tipos de cáncer ocurren con mayor frecuencia en personas de determinadas

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.

… Monday, November 25, 2013 Summary Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering. Renowned cancer biologist Joan Massagué has been named

Experts from MSK shared their work in more than 40 presentations and poster sessions at the 2023 meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology.

… Wednesday, October 4, 2023 Researchers from Memorial Sloan Kettering Cancer Center (MSK) were recognized for their achievements at the 2023 meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology. Teams reported new findings about radiation-induced secondary cancers, a new guidance

Find out when to consult a doctor for a bad headache.

… Monday, June 20, 2022 Summary MSK neuro-oncologist Lauren Schaff discusses when to see a doctor for a headache. Updated June 20, 2022 A bad headache can be a frightening experience. But sometimes, even scarier than the pounding in your head can be the tricks your mind plays on you as it’s happening.